MARKET

RGRX

RGRX

Regenerx Biopharmaceuticals
EXMKT
0.0014
0.0000
0.00%
Closed 13:08 03/24 EDT
OPEN
0.0014
PREV CLOSE
0.0014
HIGH
0.0014
LOW
0.0014
VOLUME
180
TURNOVER
0
52 WEEK HIGH
16.99
52 WEEK LOW
0.0002
MARKET CAP
2.10K
P/E (TTM)
-0.0012
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RGRX last week (0317-0321)?
Weekly Report · 1d ago
Weekly Report: what happened at RGRX last week (0310-0314)?
Weekly Report · 03/17 09:36
Weekly Report: what happened at RGRX last week (0303-0307)?
Weekly Report · 03/10 09:37
Weekly Report: what happened at RGRX last week (0224-0228)?
Weekly Report · 03/03 09:37
Weekly Report: what happened at RGRX last week (0217-0221)?
Weekly Report · 02/24 09:37
Weekly Report: what happened at RGRX last week (0210-0214)?
Weekly Report · 02/17 09:36
Weekly Report: what happened at RGRX last week (0203-0207)?
Weekly Report · 02/10 09:35
Weekly Report: what happened at RGRX last week (0127-0131)?
Weekly Report · 02/03 09:36
More
About RGRX
RegeneRx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4 (TB4), for tissue and organ protection, repair, and regeneration. The Company has formulated TB4 into three distinct product candidates in clinical development: RGN-259, RGN-352 and RGN-137. RGN-259 is a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease or other pathology. RGN-259 is in phase three clinical trials in the United States and EU for the treatment of neurotrophic keratitis, an orphan indication. RGN-352 is an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, organ damage associated with COVID-19, and other medical indications that may be treated by systemic administration. RGN-137 is a topical gel for dermal wounds and reduction of scar tissue. It has active partnerships in four territories: North America, Europe, China and Pan Asia.

Webull offers RegeneRx Biopharmaceuticals Inc stock information, including EXMKT: RGRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGRX stock methods without spending real money on the virtual paper trading platform.